About Us
Vivesto is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer.
-
Non Regulatory March 19, 2024Vivesto to hold live-streamed Paccal Vet R&D Update on March 26
-
Regulatory March 7, 2024Vivesto doses first patient in its clinical Paccal Vet trial
-
Non Regulatory January 30, 2024Vivesto’s international patent application for XR-18 receives positive decision
Year-end report 2023
Vivesto published its year-end report for 2023 on February 22, 2024, at 08.00 am CET.
The report was published in Swedish.